Inflammasome and Cancer

  • Zhiyu Wang
  • Neng Wang
  • Yifeng Zheng
  • Shengqi Wang
Part of the Experientia Supplementum book series (EXS, volume 108)


The current chapter focuses on the role of inflammasome in cancer prevention and development. Emerging evidence suggested that inflammasome is closely correlated with elevated levels of IL-1β and IL-18, activation of NF-κB signaling, enhanced mitochondrial oxidative stress, and activation of autophagic process in cancer. Meanwhile, inflammasome component NOD-like receptors (NLRs) are also involved in carcinogenesis and closely correlated to chemoresponse and prognosis. Although several lines indicated the duplex role of inflammasome in cancer development, the phenomenon might be attributed to NLR difference, cell and tissue type, cancer stage, and specific experimental conditions. Designation of inflammasome targeting strategy has become a novel tool for cancer prevention or treatment.


Inflammasome NOD-like receptors Inflammation Cancer prevention IL-1β/IL-18 



This work was supported by the National Natural science Foundation of China (81573651, 81703749 and 81703764), Guangdong Science and Technology Department (2016A030306025), Pearl River S&T Nova Program of Guangzhou (201506010098), Combined Scientific Project Funded by Guangdong Provincial Science and Technology Agency and Guangdong Provincial Academy of Traditional Chinese Medicine (2014A020221047), Guangdong Highlevel university construction project (A1-AFD018161Z1510, A1-AFD01817Z11102, A1-AFD01817Z11101), Guangdong High-level Personnel of Special Support Program (A1-3002-16-111-003) and The PhD Start-up Fund of Natural Science Foundation of Guangdong Province, China (2017A030310213).

Conflict of Interests

No potential conflicts of interest were disclosed.


  1. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, Guthrie EH, Pickles RJ, Ting JP (2009) The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30(4):556–565PubMedPubMedCentralCrossRefGoogle Scholar
  2. Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth HH, Jobin C, Rogers AB, Ting JP (2012) NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-kappaB signaling. Immunity 36(5):742–754PubMedPubMedCentralCrossRefGoogle Scholar
  3. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F et al (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13(9):1050–1059PubMedCrossRefGoogle Scholar
  4. Arthur JC, Lich JD, Ye Z, Allen IC, Gris D, Wilson JE, Schneider M, Roney KE, O'Connor BP, Moore CB, Morrison A, Sutterwala FS, Bertin J, Koller BH, Liu Z, Ting JP (2010) Cutting edge: NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivity. J Immunol 185(8):4515–4519PubMedPubMedCentralCrossRefGoogle Scholar
  5. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545PubMedCrossRefGoogle Scholar
  6. Bartsch H, Nair J (2006) Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbeck’s Arch Surg/Deutsche Gesellschaft fur Chirurgie 391(5):499–510CrossRefGoogle Scholar
  7. Bergsbaken T, Fink SL, Cookson BT (2009) Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7(2):99–109PubMedPubMedCentralCrossRefGoogle Scholar
  8. Borghini S, Tassi S, Chiesa S, Caroli F, Carta S, Caorsi R, Fiore M, Delfino L, Lasiglie D, Ferraris C, Traggiai E, Di Duca M, Santamaria G, D’Osualdo A, Tosca M, Martini A et al (2011) Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation. Arthritis Rheum 63(3):830–839PubMedPubMedCentralCrossRefGoogle Scholar
  9. Bruchard M, Mignot G, Derangere V, Chalmin F, Chevriaux A, Vegran F, Boireau W, Simon B, Ryffel B, Connat JL, Kanellopoulos J, Martin F, Rebe C, Apetoh L, Ghiringhelli F (2013) Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat Med 19(1):57–64PubMedCrossRefGoogle Scholar
  10. Bruey JM, Bruey-Sedano N, Luciano F, Zhai D, Balpai R, Xu C, Kress CL, Bailly-Maitre B, Li X, Osterman A, Matsuzawa S, Terskikh AV, Faustin B, Reed JC (2007) Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 129(1):45–56PubMedCrossRefGoogle Scholar
  11. Bryan NB, Dorfleutner A, Rojanasakul Y, Stehlik C (2009) Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain. J Immunol 182(5):3173–3182PubMedPubMedCentralCrossRefGoogle Scholar
  12. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, Sutterwala FS (2008) The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A 105(26):9035–9040PubMedPubMedCentralCrossRefGoogle Scholar
  13. Chen GY, Liu M, Wang F, Bertin J, Nunez G (2011) A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J Immunol 186(12):7187–7194PubMedPubMedCentralCrossRefGoogle Scholar
  14. Chow MT, Sceneay J, Paget C, Wong CS, Duret H, Tschopp J, Moller A, Smyth MJ (2012) NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. Cancer Res 72(22):5721–5732PubMedCrossRefGoogle Scholar
  15. Coffelt SB, Cancer d VKE (2014) Inflammation lights the way to metastasis. Nature 507(7490):48–49PubMedCrossRefGoogle Scholar
  16. Cohen EN, Gao H, Anfossi S, Mego M, Reddy NG, Debeb B, Giordano A, Tin S, Wu Q, Garza RJ, Cristofanilli M, Mani SA, Croix DA, Ueno NT, Woodward WA, Luthra R et al (2015) Inflammation mediated metastasis: immune induced epithelial-to-mesenchymal transition in inflammatory breast cancer Cells. PLoS One 10(7):e0132710PubMedPubMedCentralCrossRefGoogle Scholar
  17. Cook GP, Savic S, Wittmann M, McDermott MF (2010) The NLRP3 inflammasome, a target for therapy in diverse disease states. Eur J Immunol 40(3):631–634PubMedCrossRefGoogle Scholar
  18. Crisan TO, Plantinga TS, van de Veerdonk FL, Farcas MF, Stoffels M, Kullberg BJ, van der Meer JW, Joosten LA, Netea MG (2011) Inflammasome-independent modulation of cytokine response by autophagy in human cells. PLoS One 6(4):e18666PubMedPubMedCentralCrossRefGoogle Scholar
  19. de Alba E (2009) Structure and interdomain dynamics of apoptosis-associated speck-like protein containing a CARD (ASC). J Biol Chem 284(47):32932–32941PubMedPubMedCentralCrossRefGoogle Scholar
  20. Detjen KM, Farwig K, Welzel M, Wiedenmann B, Rosewicz S (2001) Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis. Gut 49(2):251–262PubMedPubMedCentralCrossRefGoogle Scholar
  21. Dickensheets HL, Donnelly RP (1997) IFN-gamma and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes. J Immunol 159(12):6226–6233PubMedGoogle Scholar
  22. DiDonato JA, Mercurio F, Karin M (2012) NF-kappaB and the link between inflammation and cancer. Immunol Rev 246(1):379–400PubMedCrossRefGoogle Scholar
  23. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320(5876):674–677PubMedPubMedCentralCrossRefGoogle Scholar
  24. Dostert C, Guarda G, Romero JF, Menu P, Gross O, Tardivel A, Suva ML, Stehle JC, Kopf M, Stamenkovic I, Corradin G, Tschopp J (2009) Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One 4(8):e6510PubMedPubMedCentralCrossRefGoogle Scholar
  25. Dowds TA, Masumoto J, Zhu L, Inohara N, Nunez G (2004) Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J Biol Chem 279(21):21924–21928PubMedCrossRefGoogle Scholar
  26. Duncan JA, Gao X, Huang MT, O'Connor BP, Thomas CE, Willingham SB, Bergstralh DT, Jarvis GA, Sparling PF, Ting JP (2009) Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J Immunol 182(10):6460–6469PubMedPubMedCentralCrossRefGoogle Scholar
  27. Dupaul-Chicoine J, Yeretssian G, Doiron K, Bergstrom KS, McIntire CR, LeBlanc PM, Meunier C, Turbide C, Gros P, Beauchemin N, Vallance BA, Saleh M (2010) Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32(3):367–378PubMedCrossRefPubMedCentralGoogle Scholar
  28. Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V (2011) Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1beta. EMBO J 30(23):4701–4711PubMedPubMedCentralCrossRefGoogle Scholar
  29. Eisenbarth SC, Colegio OR, O’Connor W, Sutterwala FS, Flavell RA (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453(7198):1122–1126PubMedPubMedCentralCrossRefGoogle Scholar
  30. Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon JI, Flavell RA (2011) NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145(5):745–757PubMedPubMedCentralCrossRefGoogle Scholar
  31. Fabbi M, Carbotti G, Ferrini S (2015) Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP. J Leukoc Biol 97(4):665–675PubMedCrossRefGoogle Scholar
  32. Fan Y, Mao R, Yang J (2013) NF-kappaB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell 4(3):176–185PubMedPubMedCentralCrossRefGoogle Scholar
  33. Faustin B, Chen Y, Zhai D, Le Negrate G, Lartigue L, Satterthwait A, Reed JC (2009) Mechanism of Bcl-2 and Bcl-X(L) inhibition of NLRP1 inflammasome: loop domain-dependent suppression of ATP binding and oligomerization. Proc Natl Acad Sci U S A 106(10):3935–3940PubMedPubMedCentralCrossRefGoogle Scholar
  34. Fernandes-Alnemri T, Yu JW, Juliana C, Solorzano L, Kang S, Wu J, Datta P, McCormick M, Huang L, McDermott E, Eisenlohr L, Landel CP, Alnemri ES (2010) The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 11(5):385–393PubMedPubMedCentralCrossRefGoogle Scholar
  35. Franchi L, Warner N, Viani K, Nunez G (2009) Function of nod-like receptors in microbial recognition and host defense. Immunol Rev 227(1):106–128PubMedPubMedCentralCrossRefGoogle Scholar
  36. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, Perfettini JL, Schlemmer F, Tasdemir E, Uhl M, Genin P, Civas A et al (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 15(10):1170–1178PubMedCrossRefGoogle Scholar
  37. Gross O, Thomas CJ, Guarda G, Tschopp J (2011) The inflammasome: an integrated view. Immunol Rev 243(1):136–151PubMedCrossRefGoogle Scholar
  38. Guarda G, Dostert C, Staehli F, Cabalzar K, Castillo R, Tardivel A, Schneider P, Tschopp J (2009) T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 460(7252):269–273PubMedCrossRefGoogle Scholar
  39. Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Forster I, Farlik M, Decker T, Du Pasquier RA, Romero P, Tschopp J (2011) Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34(2):213–223PubMedCrossRefGoogle Scholar
  40. Gurung P, Kanneganti TD (2015) Novel roles for caspase-8 in IL-1beta and inflammasome regulation. Am J Pathol 185(1):17–25PubMedPubMedCentralCrossRefGoogle Scholar
  41. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9(8):857–865PubMedPubMedCentralCrossRefGoogle Scholar
  42. Harris J, Hartman M, Roche C, Zeng SG, O'Shea A, Sharp FA, Lambe EM, Creagh EM, Golenbock DT, Tschopp J, Kornfeld H, Fitzgerald KA, Lavelle EC (2011) Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem 286(11):9587–9597PubMedPubMedCentralCrossRefGoogle Scholar
  43. Hawkins CJ, Uren AG, Hacker G, Medcalf RL, Vaux DL (1996) Inhibition of interleukin 1 beta-converting enzyme-mediated apoptosis of mammalian cells by baculovirus IAP. Proc Natl Acad Sci U S A 93(24):13786–13790PubMedPubMedCentralCrossRefGoogle Scholar
  44. Henry T, Brotcke A, Weiss DS, Thompson LJ, Monack DM (2007) Type I interferon signaling is required for activation of the inflammasome during Francisella infection. J Exp Med 204(5):987–994PubMedPubMedCentralCrossRefGoogle Scholar
  45. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA (2009) An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5(5):487–497PubMedPubMedCentralCrossRefGoogle Scholar
  46. Hoesel B, Schmid JA (2013) The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer 12:86PubMedPubMedCentralCrossRefGoogle Scholar
  47. Hoffman HM, Brydges SD (2011) Genetic and molecular basis of inflammasome-mediated disease. J Biol Chem 286(13):10889–10896PubMedPubMedCentralCrossRefGoogle Scholar
  48. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9(8):847–856PubMedPubMedCentralCrossRefGoogle Scholar
  49. Hu B, Elinav E, Huber S, Booth CJ, Strowig T, Jin C, Eisenbarth SC, Flavell RA (2010) Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci U S A 107(50):21635–21640PubMedPubMedCentralCrossRefGoogle Scholar
  50. Hu B, Elinav E, Flavell RA (2011) Inflammasome-mediated suppression of inflammation-induced colorectal cancer progression is mediated by direct regulation of epithelial cell proliferation. Cell Cycle 10(12):1936–1939PubMedCrossRefGoogle Scholar
  51. Hussain SP, Harris CC (2007) Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121(11):2373–2380PubMedCrossRefGoogle Scholar
  52. Huysamen C, Brown GD (2009) The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptors. FEMS Microbiol Lett 290(2):121–128PubMedCrossRefGoogle Scholar
  53. Ippagunta SK, Malireddi RK, Shaw PJ, Neale GA, Vande Walle L, Green DR, Fukui Y, Lamkanfi M, Kanneganti TD (2011) The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization. Nat Immunol 12(10):1010–1016PubMedPubMedCentralCrossRefGoogle Scholar
  54. Jeru I, Duquesnoy P, Fernandes-Alnemri T, Cochet E, Yu JW, Lackmy-Port-Lis M, Grimprel E, Landman-Parker J, Hentgen V, Marlin S, McElreavey K, Sarkisian T, Grateau G, Alnemri ES, Amselem S (2008) Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci U S A 105(5):1614–1619PubMedPubMedCentralCrossRefGoogle Scholar
  55. Jiang X, Overholtzer M, Thompson CB (2015) Autophagy in cellular metabolism and cancer. J Clin Invest 125(1):47–54PubMedPubMedCentralCrossRefGoogle Scholar
  56. Jones JW, Kayagaki N, Broz P, Henry T, Newton K, O'Rourke K, Chan S, Dong J (2010) Qu Y, Roose-Girma M, Dixit VM and Monack DM. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc Natl Acad Sci U S A 107(21):9771–9776PubMedPubMedCentralCrossRefGoogle Scholar
  57. Kanneganti TD (2010) Central roles of NLRs and inflammasomes in viral infection. Nat Rev Immunol 10(10):688–698PubMedPubMedCentralCrossRefGoogle Scholar
  58. Kanneganti TD, Lamkanfi M, Kim YG, Chen G, Park JH, Franchi L, Vandenabeele P, Nunez G (2007) Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26(4):433–443PubMedCrossRefGoogle Scholar
  59. Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441(7092):431–436PubMedCrossRefGoogle Scholar
  60. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S, Zhang J, Lee WP, Roose-Girma M, Dixit VM (2011) Non-canonical inflammasome activation targets caspase-11. Nature 479(7371):117–121PubMedCrossRefGoogle Scholar
  61. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA (2008) Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29(1):21–32PubMedPubMedCentralCrossRefGoogle Scholar
  62. Khansari N, Shakiba Y, Mahmoudi M (2009) Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Patents Inflamm Allergy Drug Discov 3(1):73–80CrossRefGoogle Scholar
  63. Kim S, Bauernfeind F, Ablasser A, Hartmann G, Fitzgerald KA, Latz E, Hornung V (2010) Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome. Eur J Immunol 40(6):1545–1551PubMedPubMedCentralCrossRefGoogle Scholar
  64. Kim JW, Koh Y, Kim DW, Ahn YO, Kim TM, Han SW, Oh DY, Lee SH, Im SA, Kim TY, Heo DS, Bang YJ (2013) Clinical Implications of VEGF, TGF-beta1, and IL-1beta in Patients with Advanced Non-small Cell Lung Cancer. Cancer Res Treat 45(4):325–333PubMedPubMedCentralCrossRefGoogle Scholar
  65. Kono H, Rock KL (2008) How dying cells alert the immune system to danger. Nat Rev Immunol 8(4):279–289PubMedPubMedCentralCrossRefGoogle Scholar
  66. Labbe K, McIntire CR, Doiron K, Leblanc PM, Saleh M (2011) Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. Immunity 35(6):897–907PubMedCrossRefGoogle Scholar
  67. Lamkanfi M, Vande Walle L, Kanneganti TD (2011) Deregulated inflammasome signaling in disease. Immunol Rev 243(1):163–173PubMedPubMedCentralCrossRefGoogle Scholar
  68. Lechtenberg BC, Mace PD, Riedl SJ (2014) Structural mechanisms in NLR inflammasome signaling. Curr Opin Struct Biol 29:17–25PubMedCrossRefGoogle Scholar
  69. Lee GS, Subramanian N, Kim AI, Aksentijevich I, Goldbach-Mansky R, Sacks DB, Germain RN, Kastner DL, Chae JJ (2012) The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492(7427):123–127PubMedPubMedCentralCrossRefGoogle Scholar
  70. Li J, Moran T, Swanson E, Julian C, Harris J, Bonen DK, Hedl M, Nicolae DL, Abraham C, Cho JH (2004) Regulation of IL-8 and IL-1beta expression in Crohn’s disease associated NOD2/CARD15 mutations. Hum Mol Genet 13(16):1715–1725PubMedCrossRefGoogle Scholar
  71. Li QX, Liu G, Wong-Staal F (2008) Oncolytic virotherapy as a personalized cancer vaccine. Int J Cancer 123(3):493–499PubMedCrossRefGoogle Scholar
  72. Li Q, Zhang X, Wang W, Li L, Xu Q, Wu X, Gu Y (2015a) CPT-11 activates NLRP3 inflammasome through JNK and NF-kappaB signalings. Toxicol Appl Pharmacol 289(2):133–141PubMedCrossRefGoogle Scholar
  73. Li J, Hu L, Liu Y, Huang L, Mu Y, Cai X, Weng C (2015b) DDX19A senses viral RNA and mediates NLRP3-dependent inflammasome activation. J Immunol 195(12):5732–5749PubMedCrossRefGoogle Scholar
  74. Liu MH (2015) FGF-21 alleviates diabetes-associated vascular complications: Inhibiting NF-kappaB/NLRP3 inflammasome-mediated inflammation? Int J Cardiol 185:320–321PubMedCrossRefGoogle Scholar
  75. Malhotra S, Rio J, Urcelay E, Nurtdinov R, Bustamante MF, Fernandez O, Oliver B, Zettl U, Brassat D, Killestein J, Lechner-Scott J, Drulovic J, Chan A, Martinelli-Boneschi F, Garcia-Merino A, Montalban X et al (2015) NLRP3 inflammasome is associated with the response to IFN-beta in patients with multiple sclerosis. Brain 138(Pt 3):644–652PubMedPubMedCentralCrossRefGoogle Scholar
  76. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436–444PubMedCrossRefGoogle Scholar
  77. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440(7081):228–232PubMedCrossRefGoogle Scholar
  78. Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10(2):417–426PubMedCrossRefPubMedCentralGoogle Scholar
  79. Martins JD, Liberal J, Silva A, Ferreira I, Neves BM, Cruz MT (2015) Autophagy and inflammasome interplay. DNA Cell Biol 34(4):274–281PubMedCrossRefGoogle Scholar
  80. Masters SL, Simon A, Aksentijevich I, Kastner DL (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 27:621–668PubMedPubMedCentralCrossRefGoogle Scholar
  81. Masters SL, Mielke LA, Cornish AL, Sutton CE, O'Donnell J, Cengia LH, Roberts AW, Wicks IP, Mills KH, Croker BA (2010) Regulation of interleukin-1beta by interferon-gamma is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production. EMBO Rep 11(8):640–646PubMedPubMedCentralCrossRefGoogle Scholar
  82. Masters SL, Gerlic M, Metcalf D, Preston S, Pellegrini M, O’Donnell JA, McArthur K, Baldwin TM, Chevrier S, Nowell CJ, Cengia LH, Henley KJ, Collinge JE, Kastner DL, Feigenbaum L, Hilton DJ et al (2012) NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells. Immunity 37(6):1009–1023PubMedPubMedCentralCrossRefGoogle Scholar
  83. Meixenberger K, Pache F, Eitel J, Schmeck B, Hippenstiel S, Slevogt H, N'Guessan P, Witzenrath M, Netea MG, Chakraborty T, Suttorp N, Opitz B (2010) Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3. J Immunol 184(2):922–930PubMedCrossRefGoogle Scholar
  84. Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A, Warren SE, Wewers MD, Aderem A (2010) Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 11(12):1136–1142PubMedPubMedCentralCrossRefGoogle Scholar
  85. Munoz-Planillo R, Franchi L, Miller LS, Nunez G (2009) A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J Immunol 183(6):3942–3948PubMedPubMedCentralCrossRefGoogle Scholar
  86. Murakami T, Ockinger J, Yu J, Byles V, McColl A, Hofer AM, Horng T (2012) Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci U S A 109(28):11282–11287PubMedPubMedCentralCrossRefGoogle Scholar
  87. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim HP, Fitzgerald KA, Ryter SW, Choi AM (2011) Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12(3):222–230PubMedCrossRefGoogle Scholar
  88. Normand S, Delanoye-Crespin A, Bressenot A, Huot L, Grandjean T, Peyrin-Biroulet L, Lemoine Y, Hot D, Chamaillard M (2011) Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci U S A 108(23):9601–9606PubMedPubMedCentralCrossRefGoogle Scholar
  89. Pan H, Chen L, Xu Y, Han W, Lou F, Fei W, Liu S, Jing Z, Sui X (2016) Autophagy-associated immune responses and cancer immunotherapy. Oncotarget 7(16):21235–21246PubMedPubMedCentralCrossRefGoogle Scholar
  90. Piccini A, Carta S, Tassi S, Lasiglie D, Fossati G, Rubartelli A (2008) ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci U S A 105(23):8067–8072PubMedPubMedCentralCrossRefGoogle Scholar
  91. Prasad S, Ravindran J, Aggarwal BB (2010) NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem 336(1-2):25–37PubMedCrossRefGoogle Scholar
  92. Qiao Y, Wang P, Qi J, Zhang L, Gao C (2012) TLR-induced NF-kappaB activation regulates NLRP3 expression in murine macrophages. FEBS Lett 586(7):1022–1026PubMedCrossRefGoogle Scholar
  93. R V (1863) Diekrankhaften Geschwülste. August Hirschwald, BerlinGoogle Scholar
  94. Rathinam VA, Vanaja SK, Fitzgerald KA (2012) Regulation of inflammasome signaling. Nat Immunol 13(4):333–342PubMedPubMedCentralCrossRefGoogle Scholar
  95. Rebecca VW, Amaravadi RK (2016) Emerging strategies to effectively target autophagy in cancer. Oncogene 35(1):1–11PubMedCrossRefGoogle Scholar
  96. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49(11):1603–1616PubMedPubMedCentralCrossRefGoogle Scholar
  97. Rossol M, Pierer M, Raulien N, Quandt D, Meusch U, Rothe K, Schubert K, Schoneberg T, Schaefer M, Krugel U, Smajilovic S, Brauner-Osborne H, Baerwald C, Wagner U (2012) Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nat Commun 3:1329PubMedPubMedCentralCrossRefGoogle Scholar
  98. Sadasivam S, Gupta S, Radha V, Batta K, Kundu TK, Swarup G (2005) Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis. Oncogene 24(4):627–636PubMedCrossRefGoogle Scholar
  99. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, Omori H, Noda T, Yamamoto N, Komatsu M, Tanaka K, Kawai T, Tsujimura T, Takeuchi O, Yoshimori T, Akira S (2008) Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456(7219):264–268PubMedCrossRefGoogle Scholar
  100. Shalapour S, Karin M (2015) Immunity, inflammation, and cancer: an eternal fight between good and evil. J Clin Invest 125(9):3347–3355PubMedPubMedCentralCrossRefGoogle Scholar
  101. Shaw PJ, Lukens JR, Burns S, Chi H, McGargill MA, Kanneganti TD (2010) Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis. J Immunol 184(9):4610–4614PubMedPubMedCentralCrossRefGoogle Scholar
  102. Shin S, Brodsky IE (2015) The inflammasome: learning from bacterial evasion strategies. Semin Immunol 27(2):102–110PubMedCrossRefGoogle Scholar
  103. Siegel RM (2006) Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol 6(4):308–317PubMedCrossRefGoogle Scholar
  104. Suarez R, Buelvas N (2015) Inflammasome: activation mechanisms. Investig Clin 56(1):74–99Google Scholar
  105. Sutterwala FS, Haasken S, Cassel SL (2014) Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci 1319:82–95PubMedPubMedCentralCrossRefGoogle Scholar
  106. Takeda K, Akira S (2005) Toll-like receptors in innate immunity. Int Immunol 17(1):1–14PubMedCrossRefGoogle Scholar
  107. Tas F, Tilgen Yasasever C, Karabulut S, Tastekin D, Duranyildiz D (2015) Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer. Biomed Pharmacother 70:19–23PubMedCrossRefGoogle Scholar
  108. van Deventer HW, Burgents JE, Wu QP, Woodford RM, Brickey WJ, Allen IC, McElvania-Tekippe E, Serody JS, Ting JP (2010) The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells. Cancer Res 70(24):10161–10169PubMedPubMedCentralCrossRefGoogle Scholar
  109. Verma D, Bivik C, Farahani E, Synnerstad I, Fredrikson M, Enerback C, Rosdahl I, Soderkvist P (2012) Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma. Pigment Cell Melanoma Res 25(4):506–513PubMedCrossRefPubMedCentralGoogle Scholar
  110. Villani AC, Lemire M, Fortin G, Louis E, Silverberg MS, Collette C, Baba N, Libioulle C, Belaiche J, Bitton A, Gaudet D, Cohen A, Langelier D, Fortin PR, Wither JE, Sarfati M et al (2009) Common variants in the NLRP3 region contribute to Crohn’s disease susceptibility. Nat Genet 41(1):71–76PubMedCrossRefPubMedCentralGoogle Scholar
  111. Vince JE, Wong WW, Gentle I, Lawlor KE, Allam R, O'Reilly L, Mason K, Gross O, Ma S, Guarda G, Anderton H, Castillo R, Hacker G, Silke J, Tschopp J (2012) Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 36(2):215–227PubMedCrossRefGoogle Scholar
  112. Wei Q, Mu K, Li T, Zhang Y, Yang Z, Jia X, Zhao W, Huai W, Guo P, Han L (2014) Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest 94(1):52–62PubMedCrossRefGoogle Scholar
  113. Willingham SB, Allen IC, Bergstralh DT, Brickey WJ, Huang MT, Taxman DJ, Duncan JA, Ting JP (2009) NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. J Immunol 183(3):2008–2015PubMedPubMedCentralCrossRefGoogle Scholar
  114. Wree A, Eguchi A, McGeough MD, Pena CA, Johnson CD, Canbay A, Hoffman HM, Feldstein AE (2014) NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 59(3):898–910PubMedPubMedCentralCrossRefGoogle Scholar
  115. Xiang P, Chen T, Mou Y, Wu H, Xie P, Lu G, Gong X, Hu Q, Zhang Y, Ji H (2015) NZ suppresses TLR4/NF-kappaB signalings and NLRP3 inflammasome activation in LPS-induced RAW264.7 macrophages. Inflamm Res 64(10):799–808PubMedCrossRefGoogle Scholar
  116. Xu Y, Li H, Chen W, Yao X, Xing Y, Wang X, Zhong J, Meng G (2013) Mycoplasma hyorhinis activates the NLRP3 inflammasome and promotes migration and invasion of gastric cancer cells. PLoS One 8(11):e77955PubMedPubMedCentralCrossRefGoogle Scholar
  117. Yang L (2010) TGFbeta and cancer metastasis: an inflammation link. Cancer Metastasis Rev 29(2):263–271PubMedCrossRefGoogle Scholar
  118. Yoneyama M, Fujita T (2007) RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. Cytokine Growth Factor Rev 18(5–6):545–551PubMedCrossRefGoogle Scholar
  119. Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD (2010a) The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32(3):379–391PubMedPubMedCentralCrossRefGoogle Scholar
  120. Zaki MH, Vogel P, Body-Malapel M, Lamkanfi M, Kanneganti TD (2010b) IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol 185(8):4912–4920PubMedPubMedCentralCrossRefGoogle Scholar
  121. Zaki MH, Vogel P, Malireddi RK, Body-Malapel M, Anand PK, Bertin J, Green DR, Lamkanfi M, Kanneganti TD (2011) The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 20(5):649–660PubMedPubMedCentralCrossRefGoogle Scholar
  122. Zhong Z, Zhai Y, Liang S, Mori Y, Han R, Sutterwala FS, Qiao L (2013) TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat Commun 4:1611PubMedPubMedCentralCrossRefGoogle Scholar
  123. Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469(7329):221–225PubMedCrossRefGoogle Scholar
  124. Zitvogel L, Kepp O, Galluzzi L, Kroemer G (2012) Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol 13(4):343–351PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Zhiyu Wang
    • 1
    • 2
  • Neng Wang
    • 1
    • 2
  • Yifeng Zheng
    • 1
  • Shengqi Wang
    • 1
  1. 1.Integrative Breast Cancer Research Laboratory, Guangdong Provincial Hospital of Chinese MedicineGuangzhou University of Chinese MedicineGuangzhouChina
  2. 2.The Research Centre for Integrative Medicine, Discipline of Integrated Chinese and Western MedicineGuangzhou University of Chinese MedicineGuangdongChina

Personalised recommendations